OneSkin targets zombie cells to reverse biological age
- Daily skin mutations create a chaotic cellular mosaic that blinds aging immune systems.
- OneSkin's OS-01 peptide cleared senescent cells and cut skin biological age by 13 years.
- Repairing cellular damage costs far less than managing chronic end-of-life diseases.
Aging is shifting from inevitable biological decay into a solvable engineering problem.
On Huberman Lab, Dr. Max Krummel detailed how environmental exposure inflicts 10,000 to 30,000 daily mutations on every human skin cell. This genomic drift turns uniform tissue into a chaotic mosaic of mutated variants. The body's 100 billion T-cells act as sensory networks, but as accumulated mutations expand the baseline definition of self, immune surveillance falters. The shrinking thymus further chokes off new T-cell production, leaving aging bodies unable to filter signal from noise.
Legacy cosmetic treatments attempt to force cellular renewal against this background noise, often making matters worse.
A day after immunologists detailed this immune breakdown, OneSkin founders outlined a targeted molecular alternative on Moonshots with Peter Diamandis. CEO Carolina de Oliveira explained that traditional retinoic acid accelerates cell turnover at the cost of spiking p16, a key biomarker of cellular senescence. Non-selective division risks exhausting the local stem cell pool and spreading localized inflammation across the skin.
To avoid that trap, OneSkin screened over 1,000 short peptides to isolate OS-01, a 10-amino-acid sequence capable of penetrating the skin barrier into the dermis. In 3D human skin models constructed from older donors, OS-01 selectively cleared senescent "zombie" cells, reducing biological age from 79 to 66 years. The company is now advancing to a ten-patient in vivo clinical trial to track epigenetic age reversal over six to twelve months of daily application.
Three days after the initial immune discussion, biogerontologist Aubrey de Grey framed these targeted repair therapies as part of a broader shift on The Peter McCormack Show. De Grey argues biological aging stems from seven distinct categories of physical damage, from intracellular garbage to stiffened extracellular matrix proteins. Therapies designed to repair that damage act as mechanical maintenance rather than permanent disease management.
De Grey places a 50 percent chance on reaching longevity escape velocity within 12 to 15 years, where medical progress repairs age-related damage faster than time inflicts it. He contends that national health authorities will eventually provide periodic damage-repair treatments free of charge. Paying for preventative cellular maintenance costs a fraction of long-term eldercare and chronic disease management.
The path forward relies on precise repair tools over forced cellular destruction.
Source Intelligence
- Deep dive into what was said in the episodes
Peter McCormack
#199 - Aubrey de Grey - The Man Who Says Ageing Can Be Cured • Aug 6
- Aubrey de Grey emphasizes that while technology cannot prevent death from accidental causes, medical science can eliminate biological aging. Society conflates the two terms because people fear thinking rationally about aging without predictable timelines.
- Aubrey de Grey estimates a 50/50 chance of reaching longevity escape velocity within 12 to 15 years. Reaching this threshold means medical advancements will extend human life expectancy faster than the rate of chronological aging.
- Aubrey de Grey defines the human body as a complex machine that accumulates molecular and cellular damage as a byproduct of normal operation. Aging is a direct consequence of physics and entropy, similar to the wear and tear on a car.
- Aubrey de Grey categorizes aging into seven distinct forms of cellular and molecular damage. Repairing these damages requires a suite of targeted therapies, ranging from stem cell replenishment to introducing enzymes that break down metabolic waste.
- Aubrey de Grey explains that macular degeneration occurs when retinal cells become overwhelmed by indigestible vitamin A byproduct molecules. A spin-out from his foundation developed enzyme therapies to successfully break down this metabolic garbage.
- Aubrey de Grey details how spontaneous chemical bonds between sugars and long-lived proteins stiffen the extracellular matrix. This process causes skin wrinkles and arteriosclerosis, which is the primary cause of high blood pressure in the elderly.
- Aubrey de Grey argues that governments will ultimately provide rejuvenation therapies for free because prevention is vastly cheaper than managing chronic late-life illnesses. Universal access will be an economic necessity for maintaining national productivity.
- Aubrey de Grey notes that AI systems like AlphaFold accelerate biological discoveries by predicting protein structures. A spin-out from his foundation utilized AlphaFold to design therapies that target and break down stiffened extracellular matrix proteins.
Also discussed on this episode: (5)
Biology (1)
- Aubrey de Grey notes that evolution dictates a species' rate of aging based on environmental hazards. Low-food-chain species age rapidly because investing energy in long-term bodily repair has no evolutionary benefit when predation rates are high.
Nutrition (1)
- Aubrey de Grey points out that calorie restriction increases lifespan significantly in smaller animals but has diminishing returns in larger mammals. Mice can live up to 40% longer under restricted diets, while dogs show only a 10% increase.
Longevity (3)
- Aubrey de Grey shifted from artificial intelligence research to biology in 1994. He was shocked to discover that mainstream biologists ignored aging, treating it as uninteresting decay rather than a medical pathology worth solving.
- Aubrey de Grey focuses on Robust Mouse Rejuvenation to prove the viability of life extension. His goal is to extend the remaining lifespan of 18-month-old mice by 8 to 12 months using a combination of damage-repair therapies.
- Aubrey de Grey describes longevity fundraising as highly unpredictable and dependent on rare, high-net-worth individuals. Venture capitalist Peter Thiel became his first major supporter 20 years ago after watching his TED talk.
Michael Kratsios on the New Golden Age of American Science | EP #276 • Aug 4
- Carolina de Oliveira explains that senescent cells make up only 1% to 5% of skin tissue but drive systemic inflammation because the skin is the largest organ. Managing this localized inflammation could potentially mitigate systemic chronic diseases like Alzheimer's.
- Carolina de Oliveira explains that OneSkin screened an initial library of 200 antimicrobial peptides in collaboration with the Catholic University of Brasilia. Through iterative optimization of 800 additional peptides, they identified the 10-amino-acid peptide OS-01.
- Carolina de Oliveira states that the 10-amino-acid size of the OS-01 peptide allows it to successfully penetrate the skin barrier into the dermis. In laboratory testing, OS-01 reduced cellular senescence levels by 25% to 50%.
- Carolina de Oliveira claims that in vitro testing on 3D human skin models reconstructed from donors aged 50 to 90 years demonstrated biological age reversal. Specifically, treatment with OS-01 reversed the biological age of skin models from 79 to 66 years.
- Carolina de Oliveira explains that OneSkin developed a proprietary algorithm to measure skin biological age. The algorithm evaluates DNA methylation patterns and was trained using a dataset of over 500 distinct skin samples.
- Carolina de Oliveira argues that while retinol accelerates cell renewal, it simultaneously increases cellular inflammation and upregulates aging-related genes like p16. Overusing retinol risks exhausting local stem cell pools due to constant, non-selective cellular division.
- Carolina de Oliveira notes that OneSkin has grown and tested more than 2,000 human skin tissue samples in vitro to validate the safety and efficacy of the OS-01 peptide. This human-model approach yields higher clinical translation success than animal testing.
- Carolina de Oliveira outlines an upcoming clinical trial that will recruit 10 patients to use the topical formulation for six months to a year. Researchers will collect biopsies behind the ear to measure biological age reversal in vivo.
- Alexandra explains that because senescent cells play active, essential roles during different phases of wound healing, OS-01 is not recommended for active wounds. However, applying the peptide to established scar tissue may help by clearing the surrounding accumulation of senescent cells.
- Alexandra reveals that OneSkin is evaluating the systemic effects of the OS-01 peptide in animal models. The company is studying whether systemic delivery can reduce obesity-related inflammation, lower cardiovascular risk, and improve cognitive performance and memory in aged subjects.
How Your Immune System Works & How to Improve It | Dr. Max Krummel • Aug 3
- Krummel explains that the human body contains approximately 10^11 T-cells, each acting as a free-agent sensor capable of measuring biomolecule concentrations like proteins and peptides. These cells react if levels fall outside their defined range.
- Krummel states aging leads to more sickness due to reduced immune cell function and production, reflecting a lack of evolutionary pressure for extreme longevity. Over years, the body becomes a genetic 'mosaic' as cells accumulate thousands of daily mutations, complicating the immune system's self-recognition.
- The thymus is large and highly active in children, producing numerous T-cells for developing immunity, but it significantly shrinks with age (involutes), reducing new T-cell output. Revitalizing the thymus is a therapeutic goal for conditions like cancer, aiming to generate new, tumor-specific T-cells.
Also discussed on this episode: (12)
Biology (5)
- Dr. Max Krummel states that when he began his immunology career roughly 30 years ago, the field was not considered robust, with molecular biology dominating scientific focus. Early immunology primarily viewed the system as identifying and eliminating foreign pathogens while otherwise remaining quiescent.
- The immune system constantly 'prunes' precancerous cells, as evidenced by white spots on skin where melanocytes have been eliminated. However, cancer's slow, insidious growth often escapes detection, as the immune system accommodates gradual changes and sees less 'weirdness.'
- The thymus is a crucial organ for T-cell development and education, ensuring these immune cells learn tolerance to the body's own tissues. Dr. Jacques Miller's early experiments (at 97 years old) proved its necessity, showing that its removal in mice led to severe infections.
- Andrew Huberman raises concerns that induced pluripotent stem cells (iPSCs) derived from adult fibroblasts might carry accumulated mutations, potentially compromising their utility for studying organoids or developing therapies. Krummel agrees, noting the challenge of ensuring iPSCs accurately replicate natural organ function.
- The immune system exhibits both migratory and resident cell populations, with some cells permanently lodged in tissues for local protection. Krummel highlights emerging research showing the insular cortex can program immune states in organs via neuronal communication, potentially through thoughts and memories.
Health (4)
- Cancer immunotherapy profoundly changed immunology, demonstrating the immune system's reactivity could be tuned to effectively target and cure certain cancers, moving beyond a simple 'foreign versus self' paradigm. Modern understanding reveals broader immune roles in the nervous system, gut, liver, and heart, continually measuring and regulating the body's health.
- Children experience frequent illnesses as their immune systems develop and encounter novel pathogens, but they typically recover quickly due to robust immune responses. Krummel notes that for the first six months, a child's immune system is less capable of training, which influences vaccination schedules.
- Krummel suggests sleep is a critical 'cleanup phase' for the body. During sleep, immune cells migrate to bone marrow, and neutrophils populate tissues for reparative processes, while lymphatic clearance improves, visibly reducing fluid retention like under-eye bags.
- Banking umbilical cord stem cells offers a straightforward way to store material useful for future bone marrow transplants, such as treating blood cancers after radiation therapy. While Krummel is confident of its efficacy based on mouse models, he's unsure of documented human cases from such banks.
Nutrition (1)
- Andrew Huberman notes that AG1 Pro, the newest formulation, includes 5 grams of creatine monohydrate to support muscle and brain health, calcium HMBB for muscle recovery, and zinc carnosine to improve gut lining. These additions build upon the existing blend of vitamins, minerals, probiotics, and adaptogens.
Science (1)
- Huberman and Krummel agree scientific progress often involves long periods of frustration and 'dead ends,' with breakthroughs like CRISPR or GLP-1 agonists emerging suddenly from curiosity-driven basic research. These 'orthogonal' discoveries often arise unexpectedly, not from direct problem-solving attempts.
Psychology (1)
- Studies suggest that the immune system is part of contextual memory, meaning recalling past positive or negative experiences can reactivate the associated immune status. This mechanism implies that conscious thoughts or practices like meditation might influence the body's inflammatory states.